Stock KAMADA LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Kamada Ltd. TEL AVIV STOCK EXCHANGE

Equities

IL0010941198

Pharmaceuticals

Business Summary

Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Sales per Business

ILS in Million2022Weight2023Weight Delta
Proprietary Products
81.0 %
345 79.3 % 426 81.0 % +23.52%
Distribution
19.0 %
90 20.7 % 100 19.0 % +11.08%

Sales per region

ILS in Million2022Weight2023Weight Delta
United States
51.7 %
-- 272 51.7 % -
Israel
22.0 %
108 24.8 % 115 22.0 % +7.25%
Latin America
9.1 %
38 8.7 % 48 9.1 % +25.66%
Canada
7.8 %
-- 41 7.8 % -
Europe
5.0 %
18 4.1 % 26 5.0 % +47.43%
Asia
4.3 %
15 3.5 % 23 4.3 % +47.29%
Others
0.1 %
1 0.2 % 1 0.1 % -43.50%

Managers

Managers TitleAgeSince
Amir London CEO
 Chief Executive Officer 55 13-12-08
David Tsur FOU
 Founder 73 90-12-12
Chaime Orlev DFI
 Director of Finance/CFO 53 17-12-30
Eran Nir COO
 Chief Operating Officer 51 16-10-31
Naveh Tov CTO
 Chief Tech/Sci/R&D Officer 60 16-06-30
Nir Livneh LAW
 General Counsel 45 09-12-31
Hanni Neheman SAM
 Sales & Marketing 54 14-07-31
Boris Gorelik PRN
 Corporate Officer/Principal - 20-03-31
Orit Pinchuk LAW
 General Counsel 59 14-09-30
Liron Reshef HRO
 Human Resources Officer - 22-12-31

Members of the board

Members of the board TitleAgeSince
Ishay Davidi BRD
 Director/Board Member 62 19-12-23
Leon Recanati BRD
 Director/Board Member 76 05-04-30
David Tsur FOU
 Founder 73 90-12-12
Lilach Asher Topilsky CHM
 Chairman 54 19-12-23
Assaf Itshayek BRD
 Director/Board Member 52 23-08-28
Lilach Payorski BRD
 Director/Board Member 50 21-12-15
Karnit Goldwasser BRD
 Director/Board Member 47 19-12-23
Benjamin Dekel BRD
 Director/Board Member - 23-08-28
Uri Botzer BRD
 Director/Board Member - 22-11-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 57,479,528 31,185,450 ( 54.25 %) 0 54.25 %

Shareholders

NameEquities%Valuation
First Israel Mezzanine Investors Ltd.
38.42 %
22,084,287 38.42 % 125 M ILa
Phoenix Investments House Ltd.
7.238 %
4,159,923 7.238 % 24 M ILa
Leon Recanati
6.070 %
3,488,886 6.070 % 20 M ILa
THE PHOENIX HOLDINGS LTD.
3.336 %
1,917,477 3.336 % 11 M ILa
Vanguard Fiduciary Trust Co.
2.130 %
1,224,226 2.130 % 7 M ILa
Renaissance Technologies LLC
1.493 %
858,363 1.493 % 5 M ILa
Wells Fargo Clearing Services LLC
1.128 %
648,516 1.128 % 4 M ILa
David Tsur
1.058 %
607,929 1.058 % 3 M ILa
Acadian Asset Management LLC
0.8954 %
514,641 0.8954 % 3 M ILa
THE PHOENIX HOLDINGS LTD.
0.3460 %
198,876 0.3460 % 1 M ILa

Company contact information

Kamada Ltd.

Science Park 2 Holzman Street

7670402, Rehovot

+

http://www.kamada.com
address Kamada Ltd.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
CSL LIMITED Stock CSL Limited
-4.66% 87.53B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 40.42B
BIOGEN INC. Stock Biogen Inc.
-19.41% 29.48B
UCB Stock UCB
+57.86% 25.43B
INCYTE CORPORATION Stock Incyte Corporation
-17.84% 11.49B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.00% 11.3B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.14% 11.1B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.24% 8.75B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-8.42% 7.99B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. KMDA Stock
  4. Stock
  5. Company Kamada Ltd.